Goldenwell Biotech dismisses BF Borgers as auditor, cites going-concern doubt in prior reports

GOLDENWELL BIOTECH, INC.

Dismissed BF Borgers CPA PC on May 14, 2024, following board approval.
BF Borgers' reports for FY 2022 and 2023 included substantial doubt about going concern.
No disagreements on accounting principles or audit scope; no reportable events occurred.
Engaged Yusufali & Associates LLC as new auditor on May 15, 2024.
No prior consultations with Yusufali on accounting matters or disagreements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.